Pathstone Holdings’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.67M Buy
22,146
+1,447
+7% +$612K 0.03% 458
2026
Q1
$9.8M Buy
20,699
+245
+1% +$123K 0.04% 354
2025
Q4
$9.55M Sell
20,454
-203
-1% -$94.2K 0.04% 352
2025
Q3
$8.8M Buy
20,657
+64
+0.3% +$24.8K 0.03% 379
2025
Q2
$7.89M Sell
20,593
-899
-4% -$324K 0.03% 403
2025
Q1
$7.42M Sell
21,492
-174
-0.8% -$56K 0.03% 428
2024
Q4
$6.5M Sell
21,666
-5,923
-21% -$2.07M 0.03% 459
2024
Q3
$11.2M Buy
27,589
+5,175
+23% +$1.89M 0.05% 294
2024
Q2
$7.2M Sell
22,414
-170
-0.8% -$55.2K 0.03% 412
2024
Q1
$7.53M Buy
22,584
+4,379
+24% +$1.34M 0.04% 391
2023
Q4
$4.93M Buy
+18,205
New +$4.5M 0.03% 439

Other funds holding HCA

Pathstone Holdings's HCA Position: Q2 2026 in Review

Pathstone Holdings increased its HCA Healthcare (HCA) stake by 7% in Q2 2026, buying an estimated $612K and bringing the position to 22,146 shares worth $8.67M. The position accounts for 0.03% of the portfolio, ranked #458.

Pathstone Holdings first reported a position in HCA in Q4 2023 and has held it in 11 quarters since. The position peaked at $11.2M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Pathstone Holdings held 22,146 shares of HCA Healthcare worth $8.67M as of Q2 2026.
  • Pathstone Holdings bought 1,447 HCA Healthcare shares in Q2 2026, an estimated $612K.
  • HCA Healthcare made up 0.03% of Pathstone Holdings's portfolio in Q2 2026, its #458 holding.
  • Pathstone Holdings first reported a position in HCA Healthcare in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's HCA Healthcare position peaked at $11.2M in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.